A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...
Amy Shapiro, MD, medical director, Indiana Hemophilia and Thrombosis Center, continues her discussion on plasminogen deficiency type 1 by highlighting the recent FDA approval of plasminogen (Ryplazim; ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Plasminogen deficiency type 1 (PLGD-1) is an ultra-rare ...
Annexin A2 is a multifunctional, calcium‐dependent phospholipid-binding protein that plays a pivotal role in cancer biology. It is implicated in a wide spectrum of processes including membrane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback